Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Mayne Pharma Group Ltd (MAYNF)

Mayne Pharma Group Ltd (MAYNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Mayne Pharma Announces Cessation of Performance Rights Tipranks - Fri Oct 17, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

MAYNF : 2.2900 (-0.87%)
Mayne Pharma Faces Delay in FIRB Approval for Acquisition by Cosette Pharmaceuticals Tipranks - Thu Oct 16, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

MAYNF : 2.2900 (-0.87%)
Mayne Pharma Awaits Court Approval for Acquisition Scheme Tipranks - Thu Oct 16, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mayne Pharma...

MAYNF : 2.2900 (-0.87%)
Mayne Pharma Wins Court Case, Advances Acquisition Scheme with Cosette Tipranks - Thu Oct 16, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

MAYNF : 2.2900 (-0.87%)
Mayne Pharma Releases 2025 Corporate Governance Statement Tipranks - Tue Oct 14, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

MAYNF : 2.2900 (-0.87%)
Mayne Pharma’s 2025 Commitment to Accessible Medications Tipranks - Tue Oct 14, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mayne Pharma...

MAYNF : 2.2900 (-0.87%)
Mayne Pharma Announces Cessation of Securities Tipranks - Tue Oct 7, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mayne Pharma...

MAYNF : 2.2900 (-0.87%)

Barchart Exclusives

Elon Musk Said Tesla Short Sellers Would Be ‘Obliterated’ Even Bill Gates — Yet They’ve Made $9 Billion This Year Shorting the Stock Barchart - 1 hour ago
Tesla short sellers have made roughly $9 billion in paper gains in 2026, two years after Elon Musk warned they’d be “obliterated” once autonomy and Optimus hit key milestones. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.